NOD2 and neoplasm: The better survival of NOD2hi COAD patients compared to NOD2lo patients confirms the importance of NOD2 signaling in the immune response against tumor, but may appear at odds with the lower carcinogenesis observed in mice with Nod2 deficiency in lysozyme-expressing myeloid cells.